FDA Increases Its DDMAC-tivity
The past few months have seen renewed vigor from FDA's DDMAC (Division of Drug Marketing, Advertising, and Communications) in scrutinizing manufacturers' claims of safety and efficacy. In particular,...
View ArticleWhy Is Pharma Stuck in Web 1.0? J&J Tries to Break Free
A nice discussion recently on BNET with J&J's Joe Natale, who is heading up J&J's first foray into website entrepreneurship.read more
View ArticleAre GSK, BMS, and J&J Pharma's Most Ethical?
If you put credence in Swiss firm Covalence's annual ethics rankings, yes, GSK, BMS, and J&J are the most ethical companies in the Pharmaceuticals and Biotech sector. The list looks like this: 1....
View ArticleMore from ISPE: J&J’s D’Eramo Finds the “c” in cGMPs
Paul D’Eramo—former ISPE chair, a two-decade veteran of FDA, and current head of Quality and Compliance Worldwide for Johnson & Johnson—always has a finger on the pulse of the regulatory...
View ArticlePharma (At Least Some of It) is All A-Twitter
No one is tracking pharma's social media presence better than WhyDotPharma, and the site/blog has done a nice review of which pharma companies are Twittering the most (Amgen, Boehringer, JNJ,...
View ArticleJ&J, BMS, Allergan, Pfizer Head Newsweek's List of Green Pharma Companies
Newsweek has just released its list of the 500 greenest companies, including sector breakdowns. Here are the top pharma companies, headed up by J&J (number 3 overall) and Bristol-Myers Squibb. read...
View ArticleEZ Pass Testing, Coercion and Buck Passing: A Tale of Broken Pharma QA and...
Just read Mina Kimes' enlightening account of the J&J McNeil quality disaster in Fortune. Forget about the fact that the adulterated products did not and most likely would not have harmed...
View ArticleDilbert, Roche, Lilly Grapple with Social Media
Drug manufacturers have been coming to grips with how to leverage social media, from Tweets to blogs, without overstepping the bounds of compliance. Johnson & Johnson and a number of companies have...
View ArticleJ&J, Baxter, BMS Sit Near Top of Newsweek's Green Rankings
Getting some good news for a change, Johnson & Johnson ranks fourth among all companies in Newsweek's annual Green Rankings, ahead of other pharmaceuticals that made the top 100, including: Baxter,...
View ArticleWithout Fanfare or Formal Announcement, ICH Q11 Now Available for Comment
The release of ICH Q11 has been anticipated for some time now. The purpose of Q11 is to take the Quality by Design concepts mapped out in ICH Q8, Q9, and Q10 and apply them more clearly and...
View Article
More Pages to Explore .....